Epidemiology and surveillance of human (neuro)cysticercosis in Europe: is enhanced surveillance required?

dc.contributor.authorAbraham, Annette
dc.contributor.authorVilhena, Maria Manuela
dc.contributor.authorGarcia, Hugo
dc.contributor.authorWinkler, Andrea Sylvia
dc.contributor.editorJohn Wiley & Sons Ltd
dc.date.accessioned2022-03-30T16:17:44Z
dc.date.available2022-03-30T16:17:44Z
dc.date.issued2020-05
dc.description.abstractobjectives To report on relevant national surveillance systems of (N)CC and taeniasis (the infection with the adult tapeworm) in the European Union/European Economic Area and to assess the magnitude of (N)CC occurrence by retrieving information on cases for the period 2000–2016. methods (N)CC cases were retrieved via national reporting systems, a systematic literature search, contact with clinicians and a search for relevant ‘International Statistical Classification of Diseases and Related Health Problems’ (ICD)-based data. results Mandatory notification systems for (N)CC were found in Hungary, Iceland and Poland. Ten cases were reported in Poland and none in Hungary and Iceland. Through the systematic literature review and information given by clinicians, 263 individual and 721 aggregated (N)CC cases from 19 European countries were identified. ICD-based data were obtained from five countries. From 2000 to 2016, a total of 3489 cases (N)CC cases were coded: 832 in Italy, eight in Latvia, 357 in Portugal, 2116 in Spain and 176 in Sweden. conclusion Despite being classified as a possible eradicable disease, (N)CC is still diagnosed across Europe, yet its true extent and impact remain unclear.por
dc.description.sponsorshipCost, Cystinetpor
dc.identifier.authoremailAnnette.Abraham@posteo.de
dc.identifier.authoremailmmcv@uevora.pt
dc.identifier.authoremailhgarcia@jhsph.edu
dc.identifier.authoremailandrea.winkler@tum.de
dc.identifier.citationAbraham A, Schmidt V, Kaminski M, Stelzle D, De Meijere R, Bustos J, Sahu PS, Garcia HH, Bobić B, Cretu C, Chiodini P, Deksne G, Dermauw V, Devleesschauwer B, Dorny P, Fonseca A, Gabriël S, Gómez-Morales MA, Kucsera I, Laranjo-González M, Trevisan C, Vilhena M, Walker NF, Zammarchi L, Winkler AS. Epidemiology and surveillance of human (neuro)cysticercosis in Europe: is enhanced surveillance required? Trop Med Int Health. 2020 May;25(5):566-578. doi: 10.1111/tmi.13384. Epub 2020 Mar 20. PMID: 32083787.por
dc.identifier.doi10.1111/tmi.13384por
dc.identifier.scientificarea236por
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/full/10.1111/tmi.13384
dc.identifier.urihttp://hdl.handle.net/10174/31656
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherTropical Medicine and International Healthpor
dc.rightsopenAccesspor
dc.subjectneurocysticercosispor
dc.subjectepidemiologypor
dc.subjectEuropepor
dc.titleEpidemiology and surveillance of human (neuro)cysticercosis in Europe: is enhanced surveillance required?por
dc.typearticlepor
degois.publication.firstPage566por
degois.publication.lastPage578por
degois.publication.locationTropical Medicine & International Healthpor
degois.publication.titleTropical Medicine & International Healthpor
degois.publication.volumeVolume25, Issue 5por

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Epidemiology and surveillance of human (neuro)cysticercosis in Europe is enhanced surveillance.pdf
Size:
463.62 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
3.89 KB
Format:
Item-specific license agreed upon to submission
Description: